A detailed history of Baird Financial Group, Inc. transactions in Penumbra Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 194,656 shares of PEN stock, worth $46.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
194,656
Previous 300,022 35.12%
Holding current value
$46.6 Million
Previous $54 Million 30.0%
% of portfolio
0.08%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.64 - $210.12 $17.2 Million - $22.1 Million
-105,366 Reduced 35.12%
194,656 $37.8 Million
Q2 2024

Aug 13, 2024

BUY
$172.27 - $223.95 $22.1 Million - $28.7 Million
128,161 Added 74.57%
300,022 $54 Million
Q1 2024

May 14, 2024

BUY
$220.09 - $273.15 $37.8 Million - $46.9 Million
171,861 New
171,861 $38.4 Million
Q2 2022

Aug 08, 2022

BUY
$116.09 - $227.33 $210,006 - $411,239
1,809 New
1,809 $225,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.06B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.